253 related articles for article (PubMed ID: 16679775)
21. Multiple binding sites revealed by interaction of relaxin family peptides with native and chimeric relaxin family peptide receptors 1 and 2 (LGR7 and LGR8).
Halls ML; Bond CP; Sudo S; Kumagai J; Ferraro T; Layfield S; Bathgate RA; Summers RJ
J Pharmacol Exp Ther; 2005 May; 313(2):677-87. PubMed ID: 15649866
[TBL] [Abstract][Full Text] [Related]
22. Coevolution of the relaxin-like peptides and their receptors.
Wilkinson TN; Speed TP; Tregear GW; Bathgate RA
Ann N Y Acad Sci; 2005 May; 1041():534-9. PubMed ID: 15956757
[TBL] [Abstract][Full Text] [Related]
23. Distribution of relaxin-3 and RXFP3 within arousal, stress, affective, and cognitive circuits of mouse brain.
Smith CM; Shen PJ; Banerjee A; Bonaventure P; Ma S; Bathgate RA; Sutton SW; Gundlach AL
J Comp Neurol; 2010 Oct; 518(19):4016-45. PubMed ID: 20737598
[TBL] [Abstract][Full Text] [Related]
24. Receptors for relaxin family peptides.
Bathgate RA; Ivell R; Sanborn BM; Sherwood OD; Summers RJ
Ann N Y Acad Sci; 2005 May; 1041():61-76. PubMed ID: 15956688
[TBL] [Abstract][Full Text] [Related]
25. Evolution of the signaling system in relaxin-family peptides.
Hsu SY; Semyonov J; Park JI; Chang CL
Ann N Y Acad Sci; 2005 May; 1041():520-9. PubMed ID: 15956755
[TBL] [Abstract][Full Text] [Related]
26. A convenient method for europium-labeling of a recombinant chimeric relaxin family peptide R3/I5 for receptor-binding assays.
Zhang WJ; Jiang Q; Wang XY; Song G; Shao XX; Guo ZY
J Pept Sci; 2013 Jun; 19(6):350-4. PubMed ID: 23526726
[TBL] [Abstract][Full Text] [Related]
27. The structural and functional role of the B-chain C-terminal arginine in the relaxin-3 peptide antagonist, R3(BDelta23-27)R/I5.
Hossain MA; Bathgate RA; Rosengren KJ; Shabanpoor F; Zhang S; Lin F; Tregear GW; Wade JD
Chem Biol Drug Des; 2009 Jan; 73(1):46-52. PubMed ID: 19152634
[TBL] [Abstract][Full Text] [Related]
28. Characterization of the mouse and rat relaxin receptors.
Scott DJ; Layfield S; Riesewijk A; Morita H; Tregear GW; Bathgate RA
Ann N Y Acad Sci; 2005 May; 1041():8-12. PubMed ID: 15956680
[TBL] [Abstract][Full Text] [Related]
29. Relaxin-3: improved synthesis strategy and demonstration of its high-affinity interaction with the relaxin receptor LGR7 both in vitro and in vivo.
Bathgate RA; Lin F; Hanson NF; Otvos L; Guidolin A; Giannakis C; Bastiras S; Layfield SL; Ferraro T; Ma S; Zhao C; Gundlach AL; Samuel CS; Tregear GW; Wade JD
Biochemistry; 2006 Jan; 45(3):1043-53. PubMed ID: 16411781
[TBL] [Abstract][Full Text] [Related]
30. Relaxin family peptide receptors--from orphans to therapeutic targets.
van der Westhuizen ET; Halls ML; Samuel CS; Bathgate RA; Unemori EN; Sutton SW; Summers RJ
Drug Discov Today; 2008 Aug; 13(15-16):640-51. PubMed ID: 18675759
[TBL] [Abstract][Full Text] [Related]
31. International Union of Pharmacology LVII: recommendations for the nomenclature of receptors for relaxin family peptides.
Bathgate RA; Ivell R; Sanborn BM; Sherwood OD; Summers RJ
Pharmacol Rev; 2006 Mar; 58(1):7-31. PubMed ID: 16507880
[TBL] [Abstract][Full Text] [Related]
32. Structure of human insulin-like peptide 5 and characterization of conserved hydrogen bonds and electrostatic interactions within the relaxin framework.
Haugaard-Jönsson LM; Hossain MA; Daly NL; Craik DJ; Wade JD; Rosengren KJ
Biochem J; 2009 May; 419(3):619-27. PubMed ID: 19178384
[TBL] [Abstract][Full Text] [Related]
33. Relaxin receptor activation in the basolateral amygdala impairs memory consolidation.
Ma S; Roozendaal B; Burazin TC; Tregear GW; McGaugh JL; Gundlach AL
Eur J Neurosci; 2005 Oct; 22(8):2117-22. PubMed ID: 16262650
[TBL] [Abstract][Full Text] [Related]
34. Development of a synthetic relaxin-3/INSL5 chimeric peptide ligand for NanoBiT complementation binding assays.
Wu H; Hoare BL; Handley TNG; Akhter Hossain M; Bathgate RAD
Biochem Pharmacol; 2024 Jun; 224():116238. PubMed ID: 38677442
[TBL] [Abstract][Full Text] [Related]
35. Distribution of relaxin-3 mRNA and immunoreactivity and RXFP3-binding sites in the brain of the macaque, Macaca fascicularis.
Ma S; Shen PJ; Sang Q; Lanciego JL; Gundlach AL
Ann N Y Acad Sci; 2009 Apr; 1160():256-8. PubMed ID: 19416198
[TBL] [Abstract][Full Text] [Related]
36. LGR7-truncate is a splice variant of the relaxin receptor LGR7 and is a relaxin antagonist in vitro.
Scott DJ; Tregear GW; Bathgate RA
Ann N Y Acad Sci; 2005 May; 1041():22-6. PubMed ID: 15956683
[TBL] [Abstract][Full Text] [Related]
37. Relaxin family peptide receptors Rxfp1 and Rxfp2: mapping of the mRNA and protein distribution in the reproductive tract of the male rat.
Filonzi M; Cardoso LC; Pimenta MT; Queiróz DB; Avellar MC; Porto CS; Lazari MF
Reprod Biol Endocrinol; 2007 Jul; 5():29. PubMed ID: 17623071
[TBL] [Abstract][Full Text] [Related]
38. Splice variants of the relaxin and INSL3 receptors reveal unanticipated molecular complexity.
Muda M; He C; Martini PG; Ferraro T; Layfield S; Taylor D; Chevrier C; Schweickhardt R; Kelton C; Ryan PL; Bathgate RA
Mol Hum Reprod; 2005 Aug; 11(8):591-600. PubMed ID: 16051677
[TBL] [Abstract][Full Text] [Related]
39. H2 relaxin is a biased ligand relative to H3 relaxin at the relaxin family peptide receptor 3 (RXFP3).
van der Westhuizen ET; Christopoulos A; Sexton PM; Wade JD; Summers RJ
Mol Pharmacol; 2010 May; 77(5):759-72. PubMed ID: 20159943
[TBL] [Abstract][Full Text] [Related]
40. Identification of binding sites with differing affinity and potency for relaxin analogues on LGR7 and LGR8 receptors.
Halls ML; Bathgate RA; Sudo S; Kumagai J; Bond CP; Summers RJ
Ann N Y Acad Sci; 2005 May; 1041():17-21. PubMed ID: 15956682
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
